Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice

[1]  G. Mancia,et al.  Blood pressure levels and control in Italy: comprehensive analysis of clinical data from 2000–2005 and 2005–2011 hypertension surveys , 2015, Journal of Human Hypertension.

[2]  Gianfranco Parati,et al.  Assessment and management of blood-pressure variability , 2014, Nature Reviews Cardiology.

[3]  K. Asayama,et al.  Day-to-Day Variability in Home Blood Pressure Is Associated With Cognitive Decline: The Ohasama Study , 2014, Hypertension.

[4]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[5]  Willie Lawrence,et al.  An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention , 2013, Hypertension.

[6]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[7]  Y. Karpov.  Blood pressure control in patients with uncontrolled hypertension by switching from the mono - or combined therapy to the fixed combination of angiotensin II converting enzyme inhibitor and calcium blocker , 2012 .

[8]  Giuseppe Mancia,et al.  Short- and long-term blood pressure variability: present and future. , 2012, Hypertension.

[9]  G. Mancia.  Short-Term and Long-Term Blood Pressure Variability , 2012 .

[10]  G. Stergiou,et al.  Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis , 2012, Journal of hypertension.

[11]  G. Parati,et al.  Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability?: evidence from day-by-day home blood pressure monitoring. , 2012, Hypertension.

[12]  E. Guallar,et al.  Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study , 2012, European journal of preventive cardiology.

[13]  K. Kario,et al.  Combined Effect of Angiotensin II Receptor Blocker and Either a Calcium Channel Blocker or Diuretic on Day-by-Day Variability of Home Blood Pressure: The Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study , 2012, Hypertension.

[14]  Giacomo Pucci,et al.  Blood pressure variability: an additional target for antihypertensive treatment? , 2011, Hypertension.

[15]  J. Wellmann,et al.  Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey , 2011, Journal of hypertension.

[16]  R. Chilton,et al.  Reducing Cardiovascular Events and End-Organ Damage in Patients with Hypertension: New Considerations , 2011, Postgraduate medicine.

[17]  K. Reynolds,et al.  The Relationship Between Visit-to-Visit Variability in Systolic Blood Pressure and All-Cause Mortality in the General Population: Findings From NHANES III, 1988 to 1994 , 2011, Hypertension.

[18]  M. Böhm,et al.  A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients , 2010, Journal of clinical hypertension.

[19]  R. Hatala,et al.  SYMBIO: RESULTS OF A LONGITUDINAL STUDY OF OPTIMIZED BLOOD PRESSURE LOWERING THERAPY WITH FIXED COMBINATION PERINDOPRIL/AMLODIPINE: PP.5.169 , 2010 .

[20]  John P A Ioannidis,et al.  Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously. , 2010, Hypertension.

[21]  E. O’Brien,et al.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension , 2010, The Lancet.

[22]  M. Caulfield,et al.  Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients – an Anglo-Scandinavian cardiac outcomes trial substudy , 2009, Journal of hypertension.

[23]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[24]  Jan A. Staessen,et al.  Daytime and Nighttime Blood Pressure as Predictors of Death and Cause-Specific Cardiovascular Events in Hypertension , 2008, Hypertension.

[25]  Yan Li,et al.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study , 2007, The Lancet.

[26]  J. Deckers,et al.  Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). , 2007, The American journal of cardiology.

[27]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[28]  S. Laurent,et al.  Brachial Pressure–Independent Reduction in Carotid Stiffness After Long-Term Angiotensin-Converting Enzyme Inhibition in Diabetic Hypertensives , 2006, Hypertension.

[29]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[30]  Alice Stanton,et al.  Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) Study , 2006, Circulation.

[31]  R H Fagard,et al.  Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice , 2005, Journal of Human Hypertension.

[32]  R. Collins,et al.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri , 2005, The Lancet.

[33]  T. Ohkubo,et al.  [The Ohasama study]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[34]  Peter W de Leeuw,et al.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.

[35]  Paolo Palatini,et al.  Performance of the UA-787 oscillometric blood pressure monitor according to the European Society of Hypertension protocol , 2003, Blood pressure monitoring.

[36]  G. Parati,et al.  Blood Pressure Variability: Mechanisms and Clinical Significance , 1990, Journal of Cardiovascular Pharmacology.

[37]  G. Parati,et al.  The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension , 1998, Journal of hypertension.

[38]  D. Rizzoni.  Beyond trough:peak ratio: a new index of the smoothness of the antihypertensive effect of a drug , 1996 .

[39]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[40]  W. Mroczek.  Diagnosis and treatment of hypertension. , 1973, American heart journal.

[41]  V. Bahl,et al.  Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study. , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.